16-1201668-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_ModerateBP6_ModerateBP7BS1BS2

The NM_021098.3(CACNA1H):​c.1218C>T​(p.Gly406Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000759 in 1,595,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Synonymous variant affecting the same amino acid position (i.e. G406G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000035 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.186

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 16-1201668-C-T is Benign according to our data. Variant chr16-1201668-C-T is described in ClinVar as Benign. ClinVar VariationId is 529631.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.186 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000466 (71/152340) while in subpopulation AFR AF = 0.00159 (66/41576). AF 95% confidence interval is 0.00128. There are 0 homozygotes in GnomAd4. There are 35 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 71 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.1179C>T p.Gly393Gly synonymous_variant Exon 9 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.1179C>T p.Gly393Gly synonymous_variant Exon 9 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.1218C>T p.Gly406Gly synonymous_variant Exon 9 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*665C>T non_coding_transcript_exon_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.1218C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*665C>T 3_prime_UTR_variant Exon 8 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.000466
AC:
71
AN:
152222
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000111
AC:
26
AN:
234518
AF XY:
0.0000626
show subpopulations
Gnomad AFR exome
AF:
0.00168
Gnomad AMR exome
AF:
0.0000299
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000955
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000347
AC:
50
AN:
1442880
Hom.:
0
Cov.:
32
AF XY:
0.0000238
AC XY:
17
AN XY:
714796
show subpopulations
African (AFR)
AF:
0.00130
AC:
43
AN:
33106
American (AMR)
AF:
0.0000457
AC:
2
AN:
43776
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25612
East Asian (EAS)
AF:
0.0000255
AC:
1
AN:
39204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84290
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4724
European-Non Finnish (NFE)
AF:
0.00000182
AC:
2
AN:
1101000
Other (OTH)
AF:
0.0000336
AC:
2
AN:
59542
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000466
AC:
71
AN:
152340
Hom.:
0
Cov.:
34
AF XY:
0.000470
AC XY:
35
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00159
AC:
66
AN:
41576
American (AMR)
AF:
0.000261
AC:
4
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68030
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000271
Hom.:
0
Bravo
AF:
0.000536

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Nov 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
7.3
DANN
Benign
0.87
PhyloP100
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375730044; hg19: chr16-1251668; API